|
GB1419788A
(en)
|
1972-08-02 |
1975-12-31 |
Pfizer |
Herbicidal method using 2-trifuluromethyl-4-quinolinols
|
|
WO1992000075A1
(en)
|
1990-06-29 |
1992-01-09 |
Pfizer Inc. |
Pyridopyrazine derivatives for treating substance abuse and addiction
|
|
DE69315920T2
(de)
|
1992-09-04 |
1998-06-10 |
Takeda Chemical Industries Ltd |
Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
|
|
US5750349A
(en)
|
1993-01-25 |
1998-05-12 |
Takeda Chemical Industries Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
|
NO309272B1
(no)
|
1995-03-24 |
2001-01-08 |
Takeda Chemical Industries Ltd |
Cykliske forbindelser, preparater inneholdende forbindelsene samt mellomprodukter for fremstilling av forbindelsene
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
AU743827B2
(en)
|
1997-04-09 |
2002-02-07 |
Intellect Neurosciences, Inc. |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
WO1999044955A1
(en)
|
1998-03-03 |
1999-09-10 |
Ppg Industries Ohio, Inc. |
Impregnated glass fiber strands and products including the same
|
|
US20020132817A1
(en)
|
1998-03-19 |
2002-09-19 |
Hideaki Natsugari |
Heterocyclic compounds, their production and use
|
|
WO2000032192A1
(fr)
|
1998-11-27 |
2000-06-08 |
Takeda Chemical Industries, Ltd. |
Medicaments
|
|
SI1481992T1
(sl)
|
2000-02-24 |
2017-01-31 |
Washington University St. Louis |
Humanizirana protitelesa, ki vežejo amiloidni peptid beta
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
WO2002042429A2
(en)
|
2000-11-03 |
2002-05-30 |
Proteotech, Inc. |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
|
|
CA2451998A1
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anti-a.beta. antibodies
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
CA2498111A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors
|
|
AU2003263518A1
(en)
|
2002-10-09 |
2004-05-04 |
Pfizer Products Inc. |
Pyrazole compounds for treatment of neurodegenerative disorders
|
|
AU2003279216A1
(en)
|
2002-10-09 |
2004-05-04 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
WO2004035577A2
(en)
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
EP1638935A1
(en)
|
2003-06-19 |
2006-03-29 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
CA2534532A1
(en)
|
2003-08-21 |
2005-03-10 |
Pfizer Products, Inc. |
Compounds for the treatment of neurodegenerative disorders
|
|
CA2538220A1
(en)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
Use of antibody
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
AU2005208887B2
(en)
|
2004-01-28 |
2010-02-25 |
Merck Sharp & Dohme Corp. |
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
|
|
BRPI0507374A
(pt)
|
2004-02-02 |
2007-07-10 |
Pfizer Prod Inc |
moduladores do receptor de histamina-3
|
|
CA2557785A1
(en)
|
2004-03-09 |
2005-10-06 |
Merck & Co. Inc. |
Hiv integrase inhibitors
|
|
US7342118B2
(en)
|
2004-03-23 |
2008-03-11 |
Pfizer Inc |
Imidazole compounds for the treatment of neurodegenerative disorders
|
|
ATE411030T1
(de)
|
2004-04-14 |
2008-10-15 |
Gilead Sciences Inc |
Phosphonatanaloga von hiv- integrasehemmerverbindungen
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
TWI355389B
(en)
|
2004-07-30 |
2012-01-01 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide a
|
|
GB0423356D0
(en)
|
2004-10-21 |
2004-11-24 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR TREATING TRAUMATIC BRAIN INJURY
|
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
|
US7741315B2
(en)
|
2005-05-10 |
2010-06-22 |
Merck Sharp & Dohme Corp. |
HIV integrase inhibitors
|
|
PT1881985E
(pt)
|
2005-05-12 |
2011-02-01 |
Pfizer |
Formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n- -etil-n-metilamino)-7-(4-metilpiridin-2-il-amino)-1h- -pirazolo[4,3-d]pirimidino-3-carbonil]metanossulfonamida
|
|
CA2603830A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Co Llc |
PYRIDINE [2,3-B] PYRAZINONES
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
CA2608672A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
EP1899296B1
(en)
|
2005-06-22 |
2010-11-17 |
Pfizer Products Inc. |
Histamine-3 receptor antagonists
|
|
US20070060534A1
(en)
|
2005-06-30 |
2007-03-15 |
Threshold Pharmaceuticals, Inc. |
Anthracycline analogs
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
EP1945639A1
(en)
|
2005-11-04 |
2008-07-23 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
|
JP2009516703A
(ja)
|
2005-11-18 |
2009-04-23 |
グラクソ グループ リミテッド |
新規中間体およびその使用
|
|
BRPI0618814A2
(pt)
|
2005-11-24 |
2014-04-29 |
Eisai R&D Man Co Ltd |
Composto ou um sal farmacologicamente aceitável do mesmo, e, agente farmacêutico
|
|
US20070117839A1
(en)
|
2005-11-24 |
2007-05-24 |
Eisai R&D Management Co., Ltd. |
Two cyclic cinnamide compound
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
RU2448964C2
(ru)
|
2006-01-20 |
2012-04-27 |
Шеринг Корпорейшн |
КАРБОЦИКЛИЧЕСКИЕ И ГЕТЕРОЦИКЛИЧЕСКИЕ АРИЛСУЛЬФОНЫ, ИХ ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, ОБЛАДАЮЩАЯ СВОЙСТВАМИ ИНГИБИТОРА γ-СЕКРЕТАЗЫ
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
EP2007749A2
(en)
|
2006-03-13 |
2008-12-31 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
|
NZ571540A
(en)
|
2006-04-21 |
2010-10-29 |
Pfizer Prod Inc |
Pyridine[3,4-b]pyrazinones for inhibiting PDE-5
|
|
US7442808B2
(en)
|
2006-05-15 |
2008-10-28 |
Merck & Co., Inc. |
Antidiabetic bicyclic compounds
|
|
AU2007254190A1
(en)
|
2006-05-16 |
2007-11-29 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
|
WO2007135969A1
(ja)
|
2006-05-19 |
2007-11-29 |
Eisai R & D Management Co., Ltd. |
ウレア系－シンナミド誘導体
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
PT2124933E
(pt)
|
2007-01-22 |
2013-01-07 |
Pfizer Prod Inc |
Sal tosilato de um composto terapêutico e composições farmacêuticas do mesmo
|
|
EP2120573A4
(en)
|
2007-02-12 |
2011-05-25 |
Merck Sharp & Dohme |
DERIVATIVES OF PIPERIDINE
|
|
US20100204230A1
(en)
|
2007-02-12 |
2010-08-12 |
Peter Blurton |
Piperazine derivatives for treatment of ad and related conditions
|
|
TW200848054A
(en)
|
2007-02-28 |
2008-12-16 |
Eisai R&D Man Co Ltd |
Two cyclic oxomorpholine derivatives
|
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
|
MX2009012177A
(es)
|
2007-05-07 |
2009-11-23 |
Schering Corp |
Moduladores de gamma-secretasa.
|
|
AU2008250436B2
(en)
|
2007-05-11 |
2013-03-28 |
F. Hoffmann-La Roche Ag |
Hetarylanilines as modulators for amyloid beta
|
|
TW200908968A
(en)
|
2007-05-29 |
2009-03-01 |
Sgx Pharmaceuticals Inc |
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
|
|
AU2008263207B2
(en)
|
2007-06-01 |
2013-10-03 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
EP2164852A2
(en)
|
2007-06-01 |
2010-03-24 |
Schering Corporation |
Gamma secretase modulators
|
|
EP2166854A4
(en)
|
2007-06-13 |
2012-05-16 |
Merck Sharp & Dohme |
TRIAZOLE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND ASSOCIATED STATES
|
|
CA2692253A1
(en)
|
2007-06-29 |
2009-01-08 |
Schering Corporation |
Gamma secretase modulators
|
|
WO2009020580A1
(en)
|
2007-08-06 |
2009-02-12 |
Schering Corporation |
Gamma secretase modulators
|
|
US7935815B2
(en)
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
JP5433418B2
(ja)
|
2007-08-31 |
2014-03-05 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
多環式化合物
|
|
JP2010538068A
(ja)
|
2007-09-06 |
2010-12-09 |
シェーリング コーポレイション |
ガンマセクレターゼモジュレーター
|
|
CN101878202A
(zh)
|
2007-09-28 |
2010-11-03 |
先灵公司 |
γ-分泌酶调节剂
|
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
|
MX2010005028A
(es)
|
2007-11-05 |
2010-05-27 |
Schering Corp |
Moduladores de gamma secretasa.
|
|
US20100298359A1
(en)
|
2007-12-06 |
2010-11-25 |
Xianhai Huang |
Gamma secretase modulators
|
|
CN101970433A
(zh)
|
2007-12-11 |
2011-02-09 |
先灵公司 |
γ分泌酶调节剂
|
|
WO2009076352A1
(en)
|
2007-12-11 |
2009-06-18 |
Schering Corporation |
Gamma secretase modulators
|
|
WO2009075874A1
(en)
|
2007-12-13 |
2009-06-18 |
Amgen Inc. |
Gamma secretase modulators
|
|
JP5306373B2
(ja)
|
2008-01-11 |
2013-10-02 |
エフ．ホフマン−ラ ロシュ アーゲー |
アミロイドβのモジュレーター
|
|
CA2713716A1
(en)
|
2008-02-22 |
2009-08-27 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
|
MX2010009454A
(es)
|
2008-02-29 |
2010-11-25 |
Schering Corp |
Moduladores de gamma secretasa para el tratamiento de la enfermedad de alzheimer.
|
|
BRPI0912539A2
(pt)
|
2008-05-05 |
2015-10-13 |
Amgen Inc |
composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
|
|
FR2933700B1
(fr)
*
|
2008-07-08 |
2010-07-30 |
Sanofi Aventis |
Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
|
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
|
EP2312946A4
(en)
|
2008-08-13 |
2012-10-24 |
Merck Sharp & Dohme |
PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
US20110251172A1
(en)
|
2008-08-13 |
2011-10-13 |
Rivkin Alexey A |
Purine derivatives for treatment of alzheimer's disease
|
|
BRPI0917144A2
(pt)
|
2008-08-27 |
2015-08-04 |
Eisai R&D Man Co Ltd |
Processo para preparar compostos, processo para preparar uma mistura, sais de d-dbta, de d-dpta e de ácido (+) -n- (1-feniletila) ftalâmico ((+) -pepa), e, composto.
|
|
CN102177151A
(zh)
|
2008-10-09 |
2011-09-07 |
弗·哈夫曼-拉罗切有限公司 |
β-淀粉样蛋白的调节剂
|
|
AU2009313524A1
(en)
|
2008-11-06 |
2010-05-14 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
US20120129846A1
(en)
|
2008-11-06 |
2012-05-24 |
Zhaoning Zhu |
Gamma secretase modulators
|
|
WO2010053438A1
(en)
|
2008-11-06 |
2010-05-14 |
Astrazeneca Ab |
Modulators of amyloid beta.
|
|
JP5378532B2
(ja)
|
2008-11-10 |
2013-12-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
複素環γ−セクレターゼモジュレーター
|
|
US8575150B2
(en)
|
2008-12-16 |
2013-11-05 |
Merck Sharp & Dohme Corp. |
Triazole derivatives for treatment of Alzheimer's disease
|
|
US20110313001A1
(en)
|
2008-12-16 |
2011-12-22 |
Christian Fischer |
Triazole derivatives for treatment of alzheimer's disease
|
|
PA8854101A1
(es)
|
2008-12-18 |
2010-07-27 |
Ortho Mcneil Janssen Pharm |
Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
|
|
MX2011005150A
(es)
|
2008-12-19 |
2011-05-30 |
Boehringer Ingelheim Int |
Pirimidin-4-carboxamidas ciclicas como antagonistas del receptor ccr2 para el tratamiento de inflamacion, asma y epoc.
|
|
TW201035103A
(en)
|
2008-12-22 |
2010-10-01 |
Schering Corp |
Gamma secretase modulators
|
|
AU2009330233A1
(en)
|
2008-12-22 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
TW201030002A
(en)
|
2009-01-16 |
2010-08-16 |
Bristol Myers Squibb Co |
Bicyclic compounds for the reduction of beta-amyloid production
|
|
WO2010089292A1
(en)
|
2009-02-06 |
2010-08-12 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc |
Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
|
|
TWI461425B
(zh)
*
|
2009-02-19 |
2014-11-21 |
Janssen Pharmaceuticals Inc |
作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類
|
|
JP2012051806A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
イミダゾリルピラジン誘導体
|
|
JP2012051807A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
アリールイミダゾール化合物
|
|
BRPI1007883A2
(pt)
|
2009-02-26 |
2016-02-23 |
Eisai R&D Man Co Ltd |
sal, e, cristal.
|
|
JP2012051805A
(ja)
|
2009-02-26 |
2012-03-15 |
Eisai R & D Management Co Ltd |
テトラヒドロトリアゾロピリジン誘導体の製造方法
|
|
JP2012121809A
(ja)
|
2009-02-26 |
2012-06-28 |
Eisai R & D Management Co Ltd |
多環式化合物の製造法およびその中間体
|
|
EP2403835A1
(en)
|
2009-03-03 |
2012-01-11 |
Pfizer Inc. |
Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
|
|
WO2011017513A1
(en)
|
2009-08-07 |
2011-02-10 |
Dow Agrosciences Llc |
Pesticidal compositions
|
|
JP2013508350A
(ja)
*
|
2009-10-20 |
2013-03-07 |
ファイザー・インク |
ガンマ−セクレターゼモジュレーターとしての新規なヘテロアリールイミダゾールおよびヘテロアリールトリアゾール
|
|
EP3808739A1
(en)
*
|
2009-12-22 |
2021-04-21 |
Vertex Pharmaceuticals Incorporated |
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
|
|
EP2691393B1
(en)
|
2011-03-31 |
2016-09-14 |
Pfizer Inc |
Novel bicyclic pyridinones
|
|
MX355164B
(es)
*
|
2012-05-16 |
2018-04-06 |
Janssen Pharmaceuticals Inc |
Derivados de 3,4-dihidro-2h-pirido[1,2-a]pirazin-1,6-diona sustituidos utiles para el tratamiento de la enfermedad de alzheimer (inter alia).
|
|
TWI614238B
(zh)
|
2012-09-21 |
2018-02-11 |
必治妥美雅史谷比公司 |
雙（氟烷基）－１，４－苯并二氮呯酮化合物及其前藥
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
WO2014096212A1
(en)
|
2012-12-20 |
2014-06-26 |
Janssen Pharmaceutica Nv |
NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
|
|
JP6283691B2
(ja)
|
2013-01-17 |
2018-02-21 |
ヤンセン ファーマシューティカ エヌ．ベー． |
γセクレターゼ調節剤としての新規な置換ピリド−ピペラジノン誘導体
|
|
JP6425717B2
(ja)
|
2013-10-04 |
2018-11-21 |
ファイザー・インク |
ガンマセクレターゼモジュレーターとしての新規二環式ピリジノン
|
|
EP3119347B1
(en)
|
2014-03-21 |
2023-06-07 |
Align Technology, Inc. |
Segmented orthodontic appliance with elastics
|
|
PE20161364A1
(es)
|
2014-04-01 |
2016-12-25 |
Pfizer |
CROMENO Y 1,1a,2,7b-TETRAHIDROCICLOPROPA [C] CROMENO PIRIDOPIRAZINADIONAS NOVEDOSAS
|